ORGN · As filed with the SEC

Origin Materials balance sheet, by quarter

The statement as Origin Materials presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

CONDENSED CONSOLIDATED BALANCE SHEETS · USD thousands

USD thousands	Q1 2026 Mar 31, 2026	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025
ASSETS
Current assets
Cash and cash equivalents	19,191	32,923	34,061	35,295
Marketable securities	13,457	20,545	20,279	34,106
Accounts receivable net of allowance for credit losses of $5,448 and $828, respectively	5,362	13,049	15,534	17,888
Other receivables	1,587	2,101	2,456	2,661
Inventory	682	684	635	687
Prepaid expenses and other current assets	1,126	2,448	2,045	1,833
Land held for sale	9,125	9,126	9,125	9,114
Total current assets	50,530	80,876	84,135	101,584
Property, plant, and equipment, net	79,726	72,852	225,744	229,068
Operating lease right-of-use asset	3,080	3,149	3,270	3,357
Intangible assets, net	24	32	51	60
Deferred tax assets	—	0	410	496
Other long-term assets	1,715	751	13,735	13,812
Total assets	135,075	157,660	327,345	348,377
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable	1,331	3,568	1,922	2,083
Accrued expenses	4,717	4,947	8,917	11,351
Operating lease liabilities, current	316	306	331	336
Notes payable, short-term	4,450	4,511	1,730	1,730
Convertible notes, net of issuance costs	6,979	14,970	—	—
Other liabilities, current	1,231	231	387	441
Total current liabilities	19,024	28,533	13,287	15,941
Earnout liability	24	24	24	24
Canadian Government Research and Development Program liability	16,496	16,776	14,876	15,132
Common stock warrants liability	89	167	518	681
Notes payable, long-term	7,654	4,386	0	1,730
Operating lease liabilities	3,449	3,533	3,612	3,689
Other liabilities, long-term	19	30	41	54
Total liabilities	46,755	53,449	32,358	37,251
STOCKHOLDERS’ EQUITY
Preferred stock, $0.0001 par value, 10,000,000 shares authorized; no shares issued and outstanding as of March 31, 2026 and December 31, 2025	0	0	0	0
Common stock, $0.0001 par value, 1,000,000,000 shares authorized; 5,499,307 and 5,173,884, issued and outstanding as of March 31, 2026 and December 31, 2025, respectively (including 50,000 and 50,000, respectively, of Sponsor Vesting Shares)	15	15	15	15
Additional paid-in capital	404,667	402,378	400,253	397,812
Accumulated deficit	(305,475)	(287,825)	(93,697)	(77,315)
Accumulated other comprehensive loss	(10,887)	(10,357)	(11,584)	(9,386)
Total stockholders’ equity	88,320	104,211	294,987	311,126
Total liabilities and stockholders’ equity	135,075	157,660	327,345	348,377

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.